The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst)
First-line ribociclib plus letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): MONALEESA-2 safety results.
 
Wolfgang Janni
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Novartis
 
Howard A. Burris
No Relationships to Disclose
 
Kimberly L. Blackwell
Consulting or Advisory Role - Advaxis; Amgen; Amgen; Bayer; Celgene; Coherus Biosciences; Eisai; G1 Therapeutics; Genentech; Incyte; Lilly; Macrogenics; Merck; Novartis; Pfizer; Pierian Biosciences; Puma Biotechnology; Roche; Sandoz; Spectrum Pharmaceuticals
Research Funding - Genentech (Inst); Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Advaxis; Amgen; Celgene; Coherus Biosciences; Eisai; Genentech; Lilly; Macrogenics; Merck; Novartis; Pfizer; Pierian Biosciences; Puma Biotechnology; Roche; Sandoz
 
Lowell L. Hart
No Relationships to Disclose
 
Arlene Chan
No Relationships to Disclose
 
Arnd Nusch
No Relationships to Disclose
 
Olga Nikolaevna Burdaeva
No Relationships to Disclose
 
Emilio Alba
Consulting or Advisory Role - Novartis; Pfizer; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Roche
 
Denise A. Yardley
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst)
 
Thomas Denis Bachelot
Honoraria - Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Roche
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Miguel J. Gil Gil
No Relationships to Disclose
 
Donald A. Richards
Consulting or Advisory Role - Boehringer Ingelheim; Insys Therapeutics; IntegraGen; Lilly; Merrimack; Pharmacyclics
Speakers' Bureau - Celgene
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - AstraZeneca; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst)
 
Joseph Gergi Kattan
No Relationships to Disclose
 
Hugues Pierre Bourgeois
No Relationships to Disclose
 
Fadi Rafic El Karak
No Relationships to Disclose
 
Bhuvaneswari Ramaswamy
No Relationships to Disclose
 
Santosh C. Sutradhar
Employment - Novartis
 
Michelle Kristine Miller
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Pier Franco Conte
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Roche/Genentech
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; celgene; Novartis